Generic drugs in oncology

Generic drugs in oncology

Beyond chemotherapy, generic drugs are also extensively used in supportive care. [...]the concerns expressed in the paper of Y Tony Yang and colleagues1 on the safety of generic drugs need to be reassessed.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet oncology 2017-02, Vol.18 (2), p.e63-e63
1. Verfasser: Leveque, Dominique
Format: Artikel
Sprache:eng
Schlagworte:
Brand names
Breast cancer
Drugs, Generic
Generic drugs
Hematology, Oncology and Palliative Medicine
Medical Oncology
Oncology
Pharmaceutical industry
Therapeutic Equivalency
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e63
container_issue 2
container_start_page e63
container_title The lancet oncology
container_volume 18
creator Leveque, Dominique
description Beyond chemotherapy, generic drugs are also extensively used in supportive care. [...]the concerns expressed in the paper of Y Tony Yang and colleagues1 on the safety of generic drugs need to be reassessed.
doi_str_mv 10.1016/S1470-2045(17)30033-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1988236198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1470204517300335</els_id><sourcerecordid>1868334999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-1dff88560f3ac7ef126a4c7f2c6bbd18109f96b0bfa1975c4cf9ef2aba1a818c3</originalsourceid><addsrcrecordid>eNqFkEtLxDAQx4Movj-AB2XBix6qmTza9KLI4gsED-o5pOlEot1Wk62w39506wO8eJph-M1vmD8h-0BPgEJ--gCioBmjQh5Bccwp5TyTK2QzjUUmhVKry35ENshWjC-UQgFUrpMNphgIAcUm2bvGFoO3kzr0z3Hi20nX2q7pnhc7ZM2ZJuLuV90mT1eXj9Ob7O7--nZ6cZdZydQ8g9o5pWROHTe2QAcsN8IWjtm8qmpQQEtX5hWtnIGykFZYV6JjpjJgFCjLt8nR6H0L3XuPca5nPlpsGtNi10cNpVKM56n8j6pccS7Kskzo4R_0petDmx4ZKJmEnEGi5EjZ0MUY0Om34GcmLDRQPcSslzHrIUMNhV7GrGXaO_iy99UM65-t71wTcD4CmJL78Bh0tB5bi7UPaOe67vy_J87-GGzjW29N84oLjL_f6Mg0HSWDIx0fDJJ_AuWqnjI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865236321</pqid></control><display><type>article</type><title>Generic drugs in oncology</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Leveque, Dominique</creator><creatorcontrib>Leveque, Dominique</creatorcontrib><description>Beyond chemotherapy, generic drugs are also extensively used in supportive care. [...]the concerns expressed in the paper of Y Tony Yang and colleagues1 on the safety of generic drugs need to be reassessed.</description><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(17)30033-5</identifier><identifier>PMID: 28214417</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Brand names ; Breast cancer ; Drugs, Generic ; Generic drugs ; Hematology, Oncology and Palliative Medicine ; Medical Oncology ; Oncology ; Pharmaceutical industry ; Therapeutic Equivalency</subject><ispartof>The lancet oncology, 2017-02, Vol.18 (2), p.e63-e63</ispartof><rights>Elsevier Ltd</rights><rights>2017 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Feb 01, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-1dff88560f3ac7ef126a4c7f2c6bbd18109f96b0bfa1975c4cf9ef2aba1a818c3</citedby><cites>FETCH-LOGICAL-c528t-1dff88560f3ac7ef126a4c7f2c6bbd18109f96b0bfa1975c4cf9ef2aba1a818c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1865236321?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28214417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leveque, Dominique</creatorcontrib><title>Generic drugs in oncology</title><title>The lancet oncology</title><addtitle>Lancet Oncol</addtitle><description>Beyond chemotherapy, generic drugs are also extensively used in supportive care. [...]the concerns expressed in the paper of Y Tony Yang and colleagues1 on the safety of generic drugs need to be reassessed.</description><subject>Brand names</subject><subject>Breast cancer</subject><subject>Drugs, Generic</subject><subject>Generic drugs</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Medical Oncology</subject><subject>Oncology</subject><subject>Pharmaceutical industry</subject><subject>Therapeutic Equivalency</subject><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkEtLxDAQx4Movj-AB2XBix6qmTza9KLI4gsED-o5pOlEot1Wk62w39506wO8eJph-M1vmD8h-0BPgEJ--gCioBmjQh5Bccwp5TyTK2QzjUUmhVKry35ENshWjC-UQgFUrpMNphgIAcUm2bvGFoO3kzr0z3Hi20nX2q7pnhc7ZM2ZJuLuV90mT1eXj9Ob7O7--nZ6cZdZydQ8g9o5pWROHTe2QAcsN8IWjtm8qmpQQEtX5hWtnIGykFZYV6JjpjJgFCjLt8nR6H0L3XuPca5nPlpsGtNi10cNpVKM56n8j6pccS7Kskzo4R_0petDmx4ZKJmEnEGi5EjZ0MUY0Om34GcmLDRQPcSslzHrIUMNhV7GrGXaO_iy99UM65-t71wTcD4CmJL78Bh0tB5bi7UPaOe67vy_J87-GGzjW29N84oLjL_f6Mg0HSWDIx0fDJJ_AuWqnjI</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Leveque, Dominique</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170201</creationdate><title>Generic drugs in oncology</title><author>Leveque, Dominique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-1dff88560f3ac7ef126a4c7f2c6bbd18109f96b0bfa1975c4cf9ef2aba1a818c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Brand names</topic><topic>Breast cancer</topic><topic>Drugs, Generic</topic><topic>Generic drugs</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Medical Oncology</topic><topic>Oncology</topic><topic>Pharmaceutical industry</topic><topic>Therapeutic Equivalency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leveque, Dominique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leveque, Dominique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Generic drugs in oncology</atitle><jtitle>The lancet oncology</jtitle><addtitle>Lancet Oncol</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>18</volume><issue>2</issue><spage>e63</spage><epage>e63</epage><pages>e63-e63</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><coden>LANCAO</coden><abstract>Beyond chemotherapy, generic drugs are also extensively used in supportive care. [...]the concerns expressed in the paper of Y Tony Yang and colleagues1 on the safety of generic drugs need to be reassessed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28214417</pmid><doi>10.1016/S1470-2045(17)30033-5</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1470-2045
ispartof The lancet oncology, 2017-02, Vol.18 (2), p.e63-e63
issn 1470-2045
1474-5488
language eng
recordid cdi_proquest_miscellaneous_1988236198
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Brand names
Breast cancer
Drugs, Generic
Generic drugs
Hematology, Oncology and Palliative Medicine
Medical Oncology
Oncology
Pharmaceutical industry
Therapeutic Equivalency
title Generic drugs in oncology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A50%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Generic%20drugs%20in%20oncology&rft.jtitle=The%20lancet%20oncology&rft.au=Leveque,%20Dominique&rft.date=2017-02-01&rft.volume=18&rft.issue=2&rft.spage=e63&rft.epage=e63&rft.pages=e63-e63&rft.issn=1470-2045&rft.eissn=1474-5488&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1470-2045(17)30033-5&rft_dat=%3Cproquest_cross%3E1868334999%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1865236321&rft_id=info:pmid/28214417&rft_els_id=1_s2_0_S1470204517300335&rfr_iscdi=true